PAWR and cancer: Loss of Par-4 expression via mechanisms such as methylation-dependent downregulation of the Par-4 promoter, inactivation of Par-4 protein by AKT-mediated phosphorylation, or spontaneous mutation, has been associated with several forms of human cancer [3,4,5,6].